USPTO serial 85886219
OLIGOMERIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 23, 2015
- Examiner
- HOWARD, PARKER WALDRIP
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with OLIGOMERIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole K. McLaughlin
Nicole K. McLaughlin Duane Morris LLP30 South 17th StreetPhiladelphia, PA 19103-4196United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products and compositions intended for medical research, namely, reagents, chemical entities and compounds; chemical preparations for scientific purposes, chemical reagents or products for laboratory analyses for monitoring, analyzing and identifying diagnostic targets and therapeutic products, and for conducting research in connection with pharmaceutical sciences; chemical preparations intended for scientific purposes, namely, for leading research in connection with pharmaceutical sciences | ACTIVE | — |
| 005 | Pharmaceutical products for the treatment of diseases, namely, Alzheimer's disease and other neurodegenerative diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; biopharmaceutical products, namely, reagents, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemical preparations for medical and pharmaceutical purposes, namely, chemicals for diagnosing Alzheimer's disease and other neurodegenerative diseases, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases | ACTIVE | — |
| 042 | Research and development of pharmaceutical molecules, compounds, inhibitors, antibodies and biological markers for diagnostic purposes and medicines for treating diseases; research and development of new products and preparations for the treatment of Alzheimer's disease and other neurodegenerative diseases; research and development in the field of pharmaceutical drugs; biological research; biotechnological research; technical research in the field of biotechnology; consultancy in the field of biotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oligomerix, Inc.
- Other trademarks owned by Oligomerix, Inc.
- Other trademarks owned by Oligomerix, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named OLIGOMERIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2025 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Oct 4, 2025 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Oct 4, 2025 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Oct 4, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 11, 2025 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jun 23, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jun 9, 2022 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 9, 2022 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 9, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 21, 2021 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jun 23, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 23, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 19, 2015 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 16, 2015 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 13, 2015 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 11, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 10, 2015 | IUAF | USE AMENDMENT FILED | — |
| Apr 10, 2015 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 10, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 6, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 11, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 11, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 22, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 3, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 3, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 11, 2014 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Sep 11, 2014 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Sep 11, 2014 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Mar 11, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 11, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 11, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 20, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 20, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 5, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2013 | NWAP | NEW APPLICATION ENTERED | — |